FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:734-735 February 17, 2005 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: In 1999, we reported on the results of a randomized study of adjuvant therapy after liver resection for metastatic colorectal cancer.¹ One group of patients was treated with hepatic arterial infusion with floxuridine and dexamethasone plus systemic fluorouracil, with or without leucovorin (combined therapy). The other group received systemic therapy alone, consisting of fluorouracil with or without leucovorin (monotherapy). We reported an increase in two-year survival for the combined-therapy group as compared with the group receiving monotherapy. We also reported a significant increase in the rate of survival free of hepatic progression in the combined-therapy group. All . . . [Full Text of this Article]

This article has been cited by other articles:

• Kemeny, N., Capanu, M., D'Angelica, M., Jarnagin, W., Haviland, D., Dematteo, R., Fong, Y. (2009). Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 20: 1236-1241 [Abstract] [Full Text]  
• Power, D. G., Kemeny, N. E. (2009). The role of floxuridine in metastatic liver disease. Molecular Cancer Therapeutics 8: 1015-1025 [Abstract] [Full Text]  
• Mitry, E., Fields, A. L.A., Bleiberg, H., Labianca, R., Portier, G., Tu, D., Nitti, D., Torri, V., Elias, D., O'Callaghan, C., Langer, B., Martignoni, G., Bouche, O., Lazorthes, F., Van Cutsem, E., Bedenne, L., Moore, M. J., Rougier, P. (2008). Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials. JCO 26: 4906-4911 [Abstract] [Full Text]  
• Alberts, S. R., Wagman, L. D. (2008). Chemotherapy for Colorectal Cancer Liver Metastases. The Oncologist 13: 1063-1073 [Abstract] [Full Text]  
• Ychou, M., Azria, D., Menkarios, C., Faurous, P., Quenet, F., Saint-Aubert, B., Rouanet, P., Pelegrin, M., Bascoul-Mollevi, C., Guerreau, D., Saccavini, J.-C., Mach, J.-P., Artus, J.-C., Pelegrin, A. (2008). Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer. Clin. Cancer Res. 14: 3487-3493 [Abstract] [Full Text]  
• Power, D. G., Leonard, G. D. (2008). Hepatic Arterial Infusion: A Treatment at the "End of an Era"?. JCO 26: 2597-2598 [Full Text]  
• Kemeny, N. (2007). Presurgical Chemotherapy in Patients Being Considered for Liver Resection. The Oncologist 12: 825-839 [Abstract] [Full Text]  
• Portier, G., Elias, D., Bouche, O., Rougier, P., Bosset, J.-F., Saric, J., Belghiti, J., Piedbois, P., Guimbaud, R., Nordlinger, B., Bugat, R., Lazorthes, F., Bedenne, L. (2006). Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial. JCO 24: 4976-4982 [Abstract] [Full Text]  
• Chong, G., Cunningham, D. (2005). Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal Cancer. JCO 23: 9063-9066 [Full Text]